Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Nimbex

Last reviewed on RxList: 8/6/2018
Nimbex Side Effects Center

Last reviewed on RxList 8/6/2018

Nimbex (cisatracurium besylate) is a skeletal muscle relaxant given before general anesthesia in preparation for surgery. Nimbex helps keep the body still during surgery. Nimbex also relaxes the throat so a breathing tube can be more easily inserted before surgery. Nimbex is available in generic form. Common side effects of Nimbex include:

Tell your doctor if you have serious side effects of Nimbex including:

  • slow heart rate,
  • noisy breathing,
  • shortness of breath,
  • ongoing muscle weakness, or
  • inability to move your muscles.

Dosage of Nimbex is individualized based on the patient's condition, weight and other factors. Nimbex may interact with lithium, seizure medications, heart rhythm medications, tetracycline antibiotics, or an aminoglycoside. Tell your doctor all medications you use. Tell your doctor if you are pregnant or plan to become pregnant during treatment with Nimbex. It is unknown if this medication passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.

Our Nimbex (cisatracurium besylate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Digestive Disorders: Common Misconceptions See Slideshow
Nimbex Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Tell your caregivers right away if you feel numb or have loss of movement in any part of your body.

Common side effects may include:

  • slow heart rate;
  • dizziness; or
  • flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Nimbex (Cisatracurium Besylate Injection)

QUESTION

About how much does an adult human brain weigh? See Answer
Nimbex Professional Information

SIDE EFFECTS

Clinical Studies Experience

Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.

Adverse Reactions In Clinical Trials Of NIMBEX In Surgical Patients

The data presented below are based on studies involving 945 surgical patients who received NIMBEX in conjunction with other drugs in US and European clinical studies in a variety of procedures [see Clinical Studies].

Table 3 displays adverse reactions that occurred at a rate of less than 1%.

Table 3. Adverse Reactions in Clinical Trials of NIMBEX in Surgical Patients

Adverse Reaction Incidence
Bradycardia 0.4%
Hypotension 0.2%
Flushing 0.2%
Bronchospasm 0.2%
Rash 0.1%

Adverse Reactions In Clinical Trials Of NIMBEX In Intensive Care Unit Patients

The adverse reactions presented below were from studies involving 68 adult ICU patients who received NIMBEX in conjunction with other drugs in US and European clinical studies [see Clinical Studies]. One patient experienced bronchospasm. In one of the two ICU studies, a randomized and double-blind study of ICU patients using TOF neuromuscular monitoring, there were two reports of prolonged recovery (range: 167 and 270 minutes) among 28 patients administered NIMBEX and 13 reports of prolonged recovery (range: 90 minutes to 33 hours) among 30 patients administered vecuronium.

Postmarketing Experience

The following events have been identified during post-approval use of NIMBEX in conjunction with one or more anesthetic agents in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to NIMBEX: anaphylaxis, histamine release, prolonged neuromuscular block, muscle weakness, myopathy.

Read the entire FDA prescribing information for Nimbex (Cisatracurium Besylate Injection)

Related Resources for Nimbex

Related Drugs

© Nimbex Patient Information is supplied by Cerner Multum, Inc. and Nimbex Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

SLIDESHOW

Digestive Disorders: Common Misconceptions See Slideshow

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW